Annual ROA
-18.66%
+10.52%+36.05%
31 December 2023
Summary:
Xeris Biopharma Holdings annual return on assets is currently -18.66%, with the most recent change of +10.52% (+36.05%) on 31 December 2023. During the last 3 years, it has risen by +49.32% (+72.55%). XERS annual ROA is now at all-time high.XERS ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-19.24%
-1.16%-6.42%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly return on assets is currently -19.24%, with the most recent change of -1.16% (-6.42%) on 30 September 2024. Over the past year, it has dropped by -0.23% (-1.21%). XERS quarterly ROA is now -6.42% below its all-time high of -18.08%, reached on 30 June 2024.XERS Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.0% | -1.2% |
| 3 y3 years | +72.5% | +68.0% |
| 5 y5 years | +74.4% | +76.8% |
XERS ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +72.5% | -6.4% | +71.3% |
| 5 y | 5 years | at high | +83.0% | -6.4% | +80.7% |
| alltime | all time | at high | +83.0% | -6.4% | +80.7% |
Xeris Biopharma Holdings ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -19.24%(+6.4%) |
| June 2024 | - | -18.08%(-8.1%) |
| Mar 2024 | - | -19.67%(+4.0%) |
| Dec 2023 | -18.66%(-36.1%) | -18.92%(-0.5%) |
| Sept 2023 | - | -19.01%(-14.0%) |
| June 2023 | - | -22.10%(-7.6%) |
| Mar 2023 | - | -23.93%(-18.7%) |
| Dec 2022 | -29.18%(-44.9%) | -29.43%(-38.0%) |
| Sept 2022 | - | -47.50%(-13.6%) |
| June 2022 | - | -54.97%(-13.0%) |
| Mar 2022 | - | -63.18%(-5.9%) |
| Dec 2021 | -52.95% | -67.14%(+11.7%) |
| Sept 2021 | - | -60.13%(+16.9%) |
| June 2021 | - | -51.43%(-0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | -51.55%(-18.5%) |
| Dec 2020 | -67.98%(-38.0%) | -63.22%(-14.8%) |
| Sept 2020 | - | -74.21%(-18.7%) |
| June 2020 | - | -91.24%(-8.6%) |
| Mar 2020 | - | -99.85%(+3.7%) |
| Dec 2019 | -109.67%(+50.6%) | -96.31%(+16.1%) |
| Sept 2019 | - | -82.96%(+20.8%) |
| June 2019 | - | -68.66%(+15.6%) |
| Mar 2019 | - | -59.39%(-0.7%) |
| Dec 2018 | -72.81%(+7.7%) | -59.79%(+17.1%) |
| Sept 2018 | - | -51.05%(+0.2%) |
| June 2018 | - | -50.94%(-19.7%) |
| Mar 2018 | - | -63.46%(+7.5%) |
| Dec 2017 | -67.63%(+71.7%) | -59.01% |
| Dec 2016 | -39.39% | - |
FAQ
- What is Xeris Biopharma Holdings annual return on assets?
- What is the all time high annual ROA for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual ROA year-on-year change?
- What is Xeris Biopharma Holdings quarterly return on assets?
- What is the all time high quarterly ROA for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly ROA year-on-year change?
What is Xeris Biopharma Holdings annual return on assets?
The current annual ROA of XERS is -18.66%
What is the all time high annual ROA for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual return on assets is -18.66%
What is Xeris Biopharma Holdings annual ROA year-on-year change?
Over the past year, XERS annual return on assets has changed by +10.52% (+36.05%)
What is Xeris Biopharma Holdings quarterly return on assets?
The current quarterly ROA of XERS is -19.24%
What is the all time high quarterly ROA for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly return on assets is -18.08%
What is Xeris Biopharma Holdings quarterly ROA year-on-year change?
Over the past year, XERS quarterly return on assets has changed by -0.23% (-1.21%)